Company Filing History:
Years Active: 2025
Title: The Innovations of James Sheppeck
Introduction
James Sheppeck is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions. His work has led to the creation of a patent that showcases his innovative approach to drug development.
Latest Patents
James Sheppeck holds a patent for 2,6,9-trisubstituted purines. This patent includes compounds having the structure of Formula (I) and pharmaceutically acceptable salts thereof. The patent outlines the use of these compounds and salts to treat or prevent cyclin-dependent kinase 2 (CDK2)-mediated conditions. Additionally, it covers pharmaceutical compositions comprising such compounds and salts, kits that include these compounds, and methods for manufacturing them.
Career Highlights
Throughout his career, James has worked with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to focus on innovative drug development and contribute to advancements in medical treatments. His expertise in the field has been instrumental in the progress of various pharmaceutical projects.
Collaborations
James has collaborated with notable colleagues, including Bernard Barlaam and Michael Steven Bodnarchuk. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical industry.
Conclusion
James Sheppeck's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the treatment of conditions related to cyclin-dependent kinase 2, showcasing the importance of innovation in healthcare.